SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950123-10-094127
Filing Date
2010-10-19
Accepted
2010-10-19 14:33:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 424(B)(5) c07055e424b5.htm 424B5 395937
2 GRAPHIC c07055o6584202.gif GRAPHIC 4633
  Complete submission text file 0000950123-10-094127.txt   403946
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-160251 | Film No.: 101130085
SIC: 2835 In Vitro & In Vivo Diagnostic Substances